Beta Drugs Limited announces 21st AGM on September 30, 2026
Beta Drugs Limited will hold its 21st Annual General Meeting on September 30, 2026. Remote e-voting is available from September 26-29, 2026. The register of members will be closed from September 24-30, 2026.
The announcement pertains to a standard annual general meeting, which is a routine procedural event for listed companies. It does not involve any significant business, financial, or strategic changes that would materially impact the company's operations or stock performance.
The announcement is a routine corporate event (AGM) and does not contain any financial or business performance-related information that would indicate a positive or negative sentiment.
Beta Drugs Limited has announced that its 21st Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 10:30 AM IST. The meeting will take place at the company's registered office located at Village Nandpur, Lodhimajra Road, Baddi, Distt Solan, Himachal Pradesh.
The company has published this notice in the Business Standard newspaper in both English and Hindi. Members are informed about the remote e-voting facility, which will commence on September 26, 2026, at 9:00 AM and conclude on September 29, 2026, at 5:00 PM. The register of members and share transfer books will remain closed from September 24, 2026, to September 30, 2026, inclusive. The cut-off date for determining eligibility for remote e-voting is September 23, 2026.
Members who have not cast their votes by remote e-voting can exercise their right through ballot paper at the AGM. Those who have already voted remotely can attend the AGM but will not be allowed to vote again. The notice of the AGM is also available on the company's website and the National Stock Exchange of India's website.
What to do with a filing like this
Beta Drugs Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Beta Drugs Limited. Read the original for the full detail.